LARCT-US
Phase 2 Unknown
280 enrolled
BRAZIL-TNT
Phase 3 Unknown
150 enrolled
RAIC
Phase 2 Unknown
38 enrolled
Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
Unknown
50 enrolled
Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Phase 3 Unknown
556 enrolled
Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer
Phase 2 Unknown
70 enrolled
CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients
Phase 3 Unknown
663 enrolled
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer
Phase 2 Unknown
17 enrolled
Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer
Phase 2 Unknown
30 enrolled
RuCorT-01
Phase 3 Unknown
560 enrolled
RuCorT-02
Phase 3 Unknown
316 enrolled
RuCorT-03
Phase 3 Unknown
540 enrolled
BJCC-R01
Unknown
54 enrolled
Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen
Phase 2 Unknown
25 enrolled
FOTAC
Phase 2 Unknown
200 enrolled
Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer
Phase 2 Unknown
119 enrolled
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Phase 1/2 Unknown
160 enrolled
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Phase 2 Unknown
100 enrolled
Multicenter, Prospective, RCT:Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.
Phase NA Unknown
1,200 enrolled
Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer
Phase 3 Unknown
1,608 enrolled
Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer
Phase 2 Unknown
45 enrolled
FOWARC
Phase 2/3 Unknown
495 enrolled
RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).
Phase 2 Unknown
110 enrolled
A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab
Phase 2 Unknown
74 enrolled
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Unknown
Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Phase 2 Unknown
20 enrolled
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
Phase 3 Unknown
340 enrolled
Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting
Phase 1/2 Unknown
45 enrolled
A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Phase 2/3 Unknown
240 enrolled
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
Phase 4 Unknown
58 enrolled
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
Phase 2 Unknown
100 enrolled
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 3 Unknown
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Phase 2/3 Unknown
600 enrolled
EXPERT-C
Phase 2 Unknown
164 enrolled
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
Phase 2 Unknown
35 enrolled
Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin
Phase 2 Unknown
206 enrolled
Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer
Phase 3 Unknown
109 enrolled
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Unknown